Dr. Christian Regenbrecht and Dr. Jens Hoffmann develop 3D cell culture models

   Dr. Christian Regenbrecht and Dr. Jens Hoffmann develop 3D cell culture models

Patient-derived 3D (PD3D®) cell cultures produced in a miniaturized petri dish-like format – this novel method could revolutionize cancer research and offer cancer patients an optimized and personalized option for cancer treatment. It all starts …

...

Read more ...

Professor Thomas Blankenstein and Dr. Martin Vaegler are developing a new cancer treatment

Professor Thomas Blankenstein and Dr. Martin Vaegler are developing a new cancer treatment

The human immune system is trained to distinguish between “self” and “non-self” and to destroy foreign structures. By means of anchor molecules (receptors) of T cells, it recognizes antigens of bacteria or viruses and thus can target and …

...

Read more ...

Professor Simone Spuler, MD, and Dr. Stefan
Kempa explore rare muscle disorders

  Professor Simone Spuler, MD, and Dr. Stefan  Kempa explore rare muscle disorders

In many cases, it is not yet possible to treat muscle disorders because the causes of muscle loss (dystrophy) have not yet been sufficiently elucidated. This is true for the around 400 genetic muscle diseases, each of which is rare, but also for …

...

Read more ...

Robert Fischer, MD and Dr. Karen Uhlmann are developing a new treatment for atrial fibrillation

Robert Fischer, MD and Dr. Karen Uhlmann are developing a new treatment for atrial fibrillation

The prospect that the first clinical trials will lead to the successful treatment of patients inspires and motivates the team of OMEICOS Therapeutics GmbH. All previous data suggest that the scientists and founders have for the first time found a …

...

Read more ...

Assistant Professor Ralf Dechend, MD, and Susann Knöfel help pregnant women with hypertension

Assistant Professor Ralf Dechend, MD,  and Susann Knöfel help  pregnant women with hypertension

In the level 1 perinatal center of HELIOS Klinikum Berlin-Buch, the head midwife Susann Knöfel often cares for pregnant women with high blood pressure (hypertension), which may be indicative of a preeclampsia. Preeclampsia, a special form of …

...

Read more ...

Nicole Folesky organizes the workflow in 11 university outpatient units of the Charité

Nicole Folesky

Care manager Nicole Folesky organizes the smooth operation of the various university outpatient units on Campus Berlin-Buch – a place where clinical research and basic research are closely intertwined. The university outpatient units are part of …

...

Read more ...

Dr. Leif Schröder detects cancer cells with the aid of a noble gas

Dr. Leif Schröder findet Krebszellen mit Hilfe eines Edelgases

To make cancer cells visible for diagnosis, the medical physicist Dr. Leif Schröder uses the same xenon gas for his research that is used in the headlights of modern cars. The brightness factor of the gas plays an important role, and the gas is …

...

Read more ...

Dr. Annette Isbruch is a specialist in Berlin-Buch for high-risk pregnancies

Dr. med. Annette Isbruch betreut in Buch Risikoschwangerschaften

For Dr. Annette Isbruch, head obstetrician/gynecologist at HELIOS Klinikum Berlin-Buch, perinatology is a family tradition. Her mother worked in the same field as a doctor in the municipal hospital in Berlin-Buch. Since the HELIOS group took over …

...

Read more ...

Dr. Ralf Krähmer provides drugs with a protective shield for their journey through the body

Dr. Ralf Krähmer schützt Medikamente mit einem Mantel für ihre Reise durch den Körper

Dr. Ralf Krähmer never thought he would one day found a company in Berlin-Buch. Following his chemistry studies in Leipzig, Dr. Krähmer went to the U.S. for a research stay. From there he went to Switzerland and then on to Berlin, where he for the …

...

Read more ...

Dr. Andreas Eckert founds and finances biotechnology and medical technology companies

Dr. Andreas Eckert gründet und finanziert Bio- und Medizintechnikfirmen

Dr. Andreas Eckert is not directly involved in research to find cures for diseases, but he has dedicated his career to the life sciences. His objective is to invest in promising companies in the early phase of their development, which he does with …

...

Read more ...